Financhill
Sell
42

PCAR Quote, Financials, Valuation and Earnings

Last price:
$105.29
Seasonality move :
7.58%
Day range:
$103.77 - $106.75
52-week range:
$90.04 - $125.50
Dividend yield:
1.11%
P/E ratio:
11.77x
P/S ratio:
1.59x
P/B ratio:
2.96x
Volume:
6.2M
Avg. volume:
2.2M
1-year change:
9.82%
Market cap:
$55.2B
Revenue:
$35.1B
EPS (TTM):
$8.95
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $25.6B $18.7B $23.5B $28.8B $35.1B
Revenue Growth (YoY) 8.96% -26.84% 25.6% 22.52% 21.89%
 
Cost of Revenues $20.8B $15.3B $19.2B $23.6B $27.5B
Gross Profit $4.8B $3.5B $4.3B $5.2B $7.6B
Gross Profit Margin 18.8% 18.49% 18.19% 18.14% 21.72%
 
R&D Expenses $326.6M $273.9M $324.1M $341.2M $410.9M
Selling, General & Admin $698.5M $581.4M $676.8M $726.3M $753.3M
Other Inc / (Exp) $82.3M $35.9M $15.5M $61M $292.2M
Operating Expenses $1.8B $1.9B $2B $1.5B $1.7B
Operating Income $3B $1.6B $2.3B $3.7B $5.9B
 
Net Interest Expenses -- -- -- -- $520.4M
EBT. Incl. Unusual Items $3.1B $1.7B $2.4B $3.8B $5.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $711.3M $360.4M $530.8M $837.1M $1.1B
Net Income to Company $2.4B $1.3B $1.9B $3B $4.6B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.4B $1.3B $1.9B $3B $4.6B
 
Basic EPS (Cont. Ops) $4.59 $2.50 $3.58 $5.76 $8.78
Diluted EPS (Cont. Ops) $4.58 $2.50 $3.57 $5.75 $8.76
Weighted Average Basic Share $520.4M $520.2M $521.7M $522.6M $523.9M
Weighted Average Diluted Share $521.3M $521.2M $522.7M $523.4M $525M
 
EBITDA $4.1B $2.6B $3.3B $4.5B $6.9B
EBIT $3B $1.6B $2.3B $3.7B $5.9B
 
Revenue (Reported) $25.6B $18.7B $23.5B $28.8B $35.1B
Operating Income (Reported) $3B $1.6B $2.3B $3.7B $5.9B
Operating Income (Adjusted) $3B $1.6B $2.3B $3.7B $5.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $4.9B $5.1B $7.1B $8.7B $8.2B
Revenue Growth (YoY) -22.48% 4.27% 37.15% 23.2% -5.25%
 
Cost of Revenues $4.1B $4.3B $5.8B $6.8B $6.7B
Gross Profit $833.8M $859M $1.3B $1.9B $1.6B
Gross Profit Margin 16.89% 16.69% 18.4% 21.92% 19.17%
 
R&D Expenses $64.7M $72.5M $82.9M $103.5M $115M
Selling, General & Admin $131.7M $168.6M $171M $182.3M $186.5M
Other Inc / (Exp) $6.4M $1.6M $21.4M $80.8M $108.7M
Operating Expenses $363.3M $384.6M $375.8M $414.2M $456.4M
Operating Income $470.5M $474.4M $923.3M $1.5B $1.1B
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $489.9M $487.2M $979.7M $1.6B $1.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $104.4M $106.7M $210.3M $360.9M $284.2M
Net Income to Company $385.5M $380.5M $769.4M $1.2B $972.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $385.5M $380.5M $769.4M $1.2B $972.1M
 
Basic EPS (Cont. Ops) $0.74 $0.73 $1.47 $2.35 $1.85
Diluted EPS (Cont. Ops) $0.74 $0.73 $1.47 $2.34 $1.85
Weighted Average Basic Share $520.2M $521.7M $522.7M $524.1M $525.4M
Weighted Average Diluted Share $521.4M $522.5M $523.3M $525.3M $526.5M
 
EBITDA $736.7M $684.3M $1.1B $1.7B $1.4B
EBIT $470.5M $474.4M $923.3M $1.5B $1.1B
 
Revenue (Reported) $4.9B $5.1B $7.1B $8.7B $8.2B
Operating Income (Reported) $470.5M $474.4M $923.3M $1.5B $1.1B
Operating Income (Adjusted) $470.5M $474.4M $923.3M $1.5B $1.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $19.3B $22.4B $27.4B $34.2B $34.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $15.8B $18.3B $22.3B $27B $27.6B
Gross Profit $3.5B $4.2B $5.1B $7.2B $7.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $285.8M $308.7M $328.4M $401.9M $446.5M
Selling, General & Admin $599.1M $659.6M $714.2M $754M $750.7M
Other Inc / (Exp) $50.3M $17.2M $28.3M $229.2M $389.7M
Operating Expenses $1.8B $2B $1.9B $1.7B $1.8B
Operating Income $1.7B $2.2B $3.2B $5.5B $5.4B
 
Net Interest Expenses -- -- -- $525.1M --
EBT. Incl. Unusual Items $1.8B $2.3B $3.3B $5.3B $5.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $400M $505.9M $724.7M $1.1B $1.2B
Net Income to Company $1.4B $1.8B $2.6B $4.1B $4.7B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.4B $1.8B $2.6B $4.1B $4.7B
 
Basic EPS (Cont. Ops) $2.74 $3.35 $4.98 $7.84 $8.97
Diluted EPS (Cont. Ops) $2.73 $3.35 $4.97 $7.83 $8.95
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $2.8B $3.4B $4.3B $6.4B $6.3B
EBIT $1.7B $2.2B $3.2B $5.5B $5.4B
 
Revenue (Reported) $19.3B $22.4B $27.4B $34.2B $34.8B
Operating Income (Reported) $1.7B $2.2B $3.2B $5.5B $5.4B
Operating Income (Adjusted) $1.7B $2.2B $3.2B $5.5B $5.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $13.2B $16.8B $20.7B $26.1B $25.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $11B $14B $17B $20.4B $20.5B
Gross Profit $2.2B $2.9B $3.7B $5.7B $5.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $202.2M $237M $241.3M $302M $337.6M
Selling, General & Admin $415.9M $494.1M $531.5M $559.2M $556.6M
Other Inc / (Exp) $30.2M $11.5M $24.3M $192.5M $290M
Operating Expenses $1.1B $1.2B $1.1B $1.2B $1.4B
Operating Income $1.1B $1.7B $2.6B $4.4B $3.9B
 
Net Interest Expenses -- -- -- $578.8M --
EBT. Incl. Unusual Items $1.1B $1.7B $2.7B $4.1B $4.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $243.5M $389M $582.9M $893.4M $961.6M
Net Income to Company $892.6M $1.3B $2.1B $3.2B $3.3B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $892.6M $1.3B $2.1B $3.2B $3.3B
 
Basic EPS (Cont. Ops) $1.72 $2.57 $4.00 $6.08 $6.27
Diluted EPS (Cont. Ops) $1.71 $2.57 $3.99 $6.07 $6.25
Weighted Average Basic Share $1.6B $1.6B $1.6B $1.6B $1.6B
Weighted Average Diluted Share $1.6B $1.6B $1.6B $1.6B $1.6B
 
EBITDA $1.8B $2.4B $3.1B $5.1B $4.6B
EBIT $1.1B $1.7B $2.6B $4.4B $3.9B
 
Revenue (Reported) $13.2B $16.8B $20.7B $26.1B $25.8B
Operating Income (Reported) $1.1B $1.7B $2.6B $4.4B $3.9B
Operating Income (Adjusted) $1.1B $1.7B $2.6B $4.4B $3.9B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $4.2B $3.5B $3.4B $4.7B $7.2B
Short Term Investments $1.2B $1.4B $1.6B $1.6B $1.8B
Accounts Receivable, Net $13.4B $13B $13.5B $15.7B $19.8B
Inventory $1.2B $1.2B $2B $2.2B $2.6B
Prepaid Expenses -- -- -- -- --
Other Current Assets $388M $515.6M $732.9M $682M $680.6M
Total Current Assets $20.3B $19.7B $21.2B $24.9B $32B
 
Property Plant And Equipment $6.5B $6.9B $6.6B $6.3B $6.1B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.6B $1.7B $1.7B $2.1B $2.7B
Total Assets $28.4B $28.3B $29.5B $33.3B $40.8B
 
Accounts Payable $1.7B $1.7B $2B $2.5B $2.7B
Accrued Expenses $1B $996.1M $1.2B $1.4B $1.6B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.1B $1.2B $1.4B $1.5B $1.8B
Total Current Liabilities $8.4B $7.3B $8.1B $9.6B $12.8B
 
Long-Term Debt $7.4B $7.7B $7.4B $8.2B $9.2B
Capital Leases -- -- -- -- --
Total Liabilities $18.7B $17.9B $17.9B $20.1B $24.9B
 
Common Stock $346.3M $346.6M $347.3M $522M $523.3M
Other Common Equity Adj -$1.1B -$1.1B -$921.1M -$953.4M -$693.9M
Common Equity $9.7B $10.4B $11.6B $13.2B $15.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $9.7B $10.4B $11.6B $13.2B $15.9B
 
Total Liabilities and Equity $28.4B $28.3B $29.5B $33.3B $40.8B
Cash and Short Terms $5.3B $5B $5B $6.3B $9B
Total Debt $11.2B $10.9B $10.4B $11.5B $14.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $3.3B $2.2B $3.3B $5.9B $6.8B
Short Term Investments $1.2B $1.5B $1.5B $1.7B $2.5B
Accounts Receivable, Net $12.7B $12.9B $14.6B $18.6B $21.5B
Inventory $1.1B $2.5B $2.4B $2.6B $2.6B
Prepaid Expenses -- -- -- -- --
Other Current Assets $541.5M $667.9M $719.7M $710.5M $665.9M
Total Current Assets $18.9B $19.8B $22.5B $29.5B $34.2B
 
Property Plant And Equipment $6.6B $6.6B $6.1B $5.9B $6.1B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.8B $1.5B $2B $2.5B $3B
Total Assets $27.2B $27.9B $30.6B $38B $43.3B
 
Accounts Payable $4B $4.4B $5.2B $6.3B $6.4B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $6.6B $7.4B $8.5B $11.3B $11.9B
 
Long-Term Debt $7.8B $6.8B $7.1B $7.9B $10B
Capital Leases -- -- -- -- --
Total Liabilities $17B $16.6B $17.7B $22B $24.6B
 
Common Stock $347M $347.2M $347.8M $523.1M $524.3M
Other Common Equity Adj -$1.2B -$1.1B -$1.4B -$937.6M -$805.4M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $10.2B $11.3B $12.9B $16B $18.7B
 
Total Liabilities and Equity $27.2B $27.9B $30.6B $38B $43.3B
Cash and Short Terms $4.5B $3.8B $4.9B $7.6B $9.4B
Total Debt $10.4B $9.9B $10.4B $12.9B $15.5B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $2.4B $1.3B $1.9B $3B $4.6B
Depreciation & Amoritzation $1.1B $1B $903.3M $790.2M $923.9M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$592.5M $993M -$322.1M -$1.4B -$1.7B
Change in Inventories $24.6M -$51.9M -$628M -$272.7M -$350.7M
Cash From Operations $2.9B $3B $2.2B $3B $4.2B
 
Capital Expenditures $2B $1.6B $1.6B $1.4B $1.3B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.2B -$1.9B -$1.4B -$2B -$2.9B
 
Dividends Paid (Ex Special Dividend) -$1.1B -$1.2B -$708M -$1B -$1.5B
Special Dividend Paid
Long-Term Debt Issued $2.5B $2.2B $2.1B $3.2B $3.1B
Long-Term Debt Repaid -$1.8B -$1.9B -$2.3B -$2.3B -$2.2B
Repurchase of Common Stock -$110.2M -$42.1M -$1.5M -$2.1M -$3.5M
Other Financing Activities -- -- -- -- --
Cash From Financing $83.4M -$1.8B -$882.9M $304.9M $1.1B
 
Beginning Cash (CF) $3.4B $4.2B $3.5B $3.4B $4.7B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $736.3M -$697.1M -$58.9M $1.3B $2.4B
Ending Cash (CF) $4.2B $3.5B $3.4B $4.7B $7.2B
 
Levered Free Cash Flow $889.5M $1.3B $553.9M $1.6B $2.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $385.5M $380.5M $769.4M $1.2B $972.1M
Depreciation & Amoritzation $266.2M $209.9M $203M $233.9M $226.8M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$6.6M $450.1M -$128.8M -$229.9M $47.1M
Change in Inventories $27.4M -$505.9M -$215.6M $44.3M $176.9M
Cash From Operations $831.7M $282.5M $680.7M $1.3B $1.3B
 
Capital Expenditures $381.1M $378.5M $342.5M $335.7M $378.1M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$440.2M -$358.7M -$439.5M -$886.4M -$1.2B
 
Dividends Paid (Ex Special Dividend) -$110.9M -$118.1M -$118.3M -$141.3M -$157.3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $556.5M $372.4M $654.4M $816.7M $1.6B
Long-Term Debt Repaid -$406.7M -$661.7M -$723M -$757.8M -$805.8M
Repurchase of Common Stock -- -$100K -$100K -$100K -$500K
Other Financing Activities -- -- -- -- --
Cash From Financing -$209.6M -$738.4M -$72.9M $358.1M $812.9M
 
Beginning Cash (CF) $3.1B $3.1B $3.2B $5.1B $5.9B
Foreign Exchange Rate Adjustment $34.4M -$27.4M -$76.1M -$54.3M $64.1M
Additions / Reductions $181.9M -$814.6M $168.3M $814.7M $913.6M
Ending Cash (CF) $3.3B $2.2B $3.3B $5.9B $6.8B
 
Levered Free Cash Flow $450.6M -$96M $338.2M $1B $908.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.4B $1.8B $2.6B $4.1B $4.7B
Depreciation & Amoritzation $1.1B $961.8M $796.6M $883M $939.2M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $1.1B $553.2M -$1.7B -$1.8B -$1B
Change in Inventories $171.7M -$1.4B $197.7M -$199.2M $13M
Cash From Operations $3.1B $1.9B $2.8B $4.3B $4.4B
 
Capital Expenditures $1.7B $1.7B $1.5B $1.2B $1.6B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.7B -$1.9B -$1.7B -$2.6B -$3.7B
 
Dividends Paid (Ex Special Dividend) -$1.2B -$700.8M -$994M -$1.5B -$2.3B
Special Dividend Paid
Long-Term Debt Issued $2.5B $1.9B $2.6B $3.3B $4.1B
Long-Term Debt Repaid -$1.5B -$2.8B -$2.1B -$2.4B -$2.1B
Repurchase of Common Stock -$41.6M -$2M -$2M -$3.2M -$4.9M
Other Financing Activities -- -- -- -- --
Cash From Financing -$1.8B -$1.2B $88.1M $883.3M $176.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$364.9M -$1.1B $1.2B $2.5B $863M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.5B $267.6M $1.3B $3B $2.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $892.6M $1.3B $2.1B $3.2B $3.3B
Depreciation & Amoritzation $779.5M $692.3M $585.6M $678.4M $693.7M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $718.5M $278.7M -$1.1B -$1.5B -$874.1M
Change in Inventories $11.9M -$1.3B -$523.5M -$450M -$86.3M
Cash From Operations $2.2B $1.2B $1.8B $3B $3.2B
 
Capital Expenditures $1.1B $1.2B $1.1B $899.1M $1.2B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1B -$1B -$1.3B -$1.9B -$2.8B
 
Dividends Paid (Ex Special Dividend) -$1.1B -$589.9M -$875.9M -$1.4B -$2.1B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2B $1.8B $2.3B $2.4B $3.4B
Long-Term Debt Repaid -$1.4B -$2.3B -$2.1B -$2.2B -$2.1B
Repurchase of Common Stock -$41.6M -$1.5M -$2M -$3.1M -$4.5M
Other Financing Activities -- -- -- -- --
Cash From Financing -$2B -$1.4B -$418.9M $159.5M -$766.4M
 
Beginning Cash (CF) $10.6B $9.9B $10B $14.2B $19.2B
Foreign Exchange Rate Adjustment -$1M -$46.7M -$145.6M -$16.3M -$6M
Additions / Reductions -$829.8M -$1.3B $40.8M $1.2B -$326.5M
Ending Cash (CF) $9.8B $8.6B $9.9B $15.5B $18.9B
 
Levered Free Cash Flow $1.1B -$21.6M $696.4M $2.1B $2B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock